<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7140116/figure_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption> SAMHD1 modifies antiviral and activity of antimetabolites. Dose response of the nucleoside analogues ( A) or anti-folate drugs ( B) currently used as anti-cancer treatments in wild-type (■) or SAMHD1-depleted (Δ) MDMs. Inhibition of HIV infection was measured as the percentage of GFP+ cells relative to the no drug condition. Mean ±SD of at least three independent donors performed in duplicate is shown. * p &lt; 0.05; ** p &lt; 0.005; *** p &lt; 0.0005. </caption>
 <div class="graphic"/>
 <p class="label">Figure 2</p>
</div>
